Compounds of formula (I):
wherein B, X, R
3
, L
0
, L
1
, L
2
, R
2
, R
1
and R
C
are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
[EN] HEPATITIS C INHIBITOR COMPOUNDS<br/>[FR] COMPOSES INHIBITEURS DE L'HEPATITE C
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2004103996A1
公开(公告)日:2004-12-02
Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.